HPV vaccination coverage in French girls attending middle and high schools: a declarative cross sectional study in the department of Cote d'Or

被引:7
作者
Bertaut, Aurelie [1 ,5 ]
Chavanet, Pascal [2 ,3 ]
Aho, Serge [1 ]
Astruc, Karine [1 ]
Douvier, Serge [4 ]
Fournel, Isabelle [1 ,6 ]
机构
[1] CHU Dijon, Hosp Hyg & Epidemiol Unit, F-21079 Dijon, France
[2] CHU Dijon, Dept Infect Dis, F-21079 Dijon, France
[3] Antimicrobial PKPD Evaluat, Infect Dis Lab, EA 562, Dijon, France
[4] CHU Dijon, Dept Gynecol & Oncol Surg, F-21079 Dijon, France
[5] Ctr Georges Francois Leclerc, Breast & Gynecol Canc Registry Cote dOr, EA 4184, Dijon, France
[6] INSERM, CIE1, F-75654 Paris 13, France
关键词
Papillomavirus vaccines; Vaccination coverage; Cervical cancer; Prevention; Adolescent; HUMAN-PAPILLOMAVIRUS VACCINE; COST-EFFECTIVENESS; CERVICAL-CANCER; ACCEPTANCE; STUDENTS; COHORT;
D O I
10.1016/j.ejogrb.2013.07.028
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To assess human papillomavirus prophylactic vaccine coverage among a representative population of French girls, aged 14 years and above, attending middle and high schools, and to determine factors associated with the initiation and completion of the vaccination protocol. Study design: This cross-sectional study, designed with cluster sampling, was conducted from October 2010 to May 2011, in 29 schools in the department of Cote d'Or, France. The schools were randomized according to their status (public or private) and location (rural or urban). Two classes per level were then included. All analyses were stratified on age. Results: 948 questionnaires were collected (87.9% participation). Mean age was 15.2 years (SD = 1.3), ranging between 14 and 19. Only 31.7% of 14-year-old girls and 61.4% of girls aged 15 and above initiated vaccination (one dose), and 7.8% of 14-year-old girls and 48.5% of girls aged 15 and above completed it (three doses). An urban school location and a physician's recommendation were independently associated with vaccination initiation in girls aged 14. In girls aged 15 and above, the parents' socioeconomic status, the family composition and a recommendation by a physician were independently associated with vaccination initiation. Once vaccination had been initiated, girls who attended private school, who belonged to families with higher outcomes, who lived with a single parent or who smoked were less likely to complete the vaccination protocol. Conclusion: HPV prophylactic vaccine coverage in girls attending school in Cote d'Or appears to be low. Physicians play a major role in vaccine acceptance. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:526 / 532
页数:7
相关论文
共 27 条
  • [1] Human papilloma virus (HPV) prophylactic vaccination: Challenges for public health and implications for screening
    Adams, M.
    Jasani, B.
    Fiander, A.
    [J]. VACCINE, 2007, 25 (16) : 3007 - 3013
  • [2] Prophylaxis of Cervical Cancer and Related Cervical Disease: A Review of the Cost-Effectiveness of Vaccination Against Oncogenic HPV Types
    Armstrong, Edward P.
    [J]. JOURNAL OF MANAGED CARE PHARMACY, 2010, 16 (03): : 217 - 230
  • [3] Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France
    Bergeron, Christine
    Largeron, Nathalie
    McAllister, Ruth
    Mathevet, Patrice
    Remy, Vanessa
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2008, 24 (01) : 10 - 19
  • [4] High incidence of cervical human papillomavirus infection in women during their first sexual relationship
    Collins, S
    Mazloomzadeh, S
    Winter, H
    Blomfield, P
    Bailey, A
    Young, LS
    Woodman, CBJ
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2002, 109 (01) : 96 - 98
  • [5] Selecting a Mix of Prevention Strategies against Cervical Cancer for Maximum Efficiency with an Optimization Program
    Demarteau, Nadia
    Breuer, Thomas
    Standaert, Baudouin
    [J]. PHARMACOECONOMICS, 2012, 30 (04) : 337 - 353
  • [6] HPV vaccine acceptance, utilization and expected impacts in the US Where are we now?
    Dempsey, Amanda F.
    Patel, Divya A.
    [J]. HUMAN VACCINES, 2010, 6 (09): : 715 - 720
  • [7] Dervaux B, 2012, MODELISATION MEDICO
  • [8] HPV vaccination in France: Uptake, costs and issues for the National Health Insurance
    Fagot, Jean-Paul
    Boutrelle, Aurelie
    Ricordeau, Philippe
    Weill, Alain
    Allemand, Hubert
    [J]. VACCINE, 2011, 29 (19) : 3610 - 3616
  • [9] Institut National du Cancer. Inca, 2012, INC DONN CANC COL ET
  • [10] Factors influencing acceptance of human papillomavirus vaccine among young female college students in Thailand
    Juntasopeepun, Phanida
    Suwan, Natthawan
    Phianmongkhol, Yupin
    Srisomboon, Jatupol
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2012, 118 (03) : 247 - 250